About Entrechem  >  Business Consultants

the company   ı   founders   ı   key personnel   ı   scientific collaborators   ı   business consultants

EntreChem has buit an international network of collaborators in the area of Business Development, most prefer their names to stay confidential, but everyone actively helps EntreChem disseminate our drug development programs, and get in the radar of potential licensees.

Linda M. Pullan, Ph.D.

Linda M. Pullan offers biotech and pharmaceutical companies consulting in all aspects of partnering. She has a Ph.D. in Biochemistry and a B.S. in Chemistry.

Linda has over 20 years of drug industry experience, beginning in drug discovery at Monsanto/Searle/now Pfizer and ICI/Zeneca/now AstraZeneca. She contributed to and led teams that put the multi-billion dollar antipsychotic Seroquel and other molecules into development.

Her business development experiences began with in-licensing technology and early drug candidates in all therapeutic areas at what is now AstraZeneca, and continued as head of oncology and hematology licensing for Amgen, and Kosan Biosciences as VP of Business Development.

For several years, she has been providing companies help in strategy, presentations and messaging, identification, evaluation, valuation, negotiation for partnering in or out. She has an extensive deal sheet ranging from company acquisitions to Phase III compounds to preclinical candidates to technologies.

She writes a free monthly newsletter Pullan's Pieces (see back issues on www.PullanConsulting.com ), with tidbits of science and business for thousands of readers.